Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Lerario, Alberto ^a,g   Bonfiglio, Serena ^a,g   Sormani, MariaPia ^b,g   Tettamanti, Andrea ^c,g   Marktel, Sarah ^d,g   Napolitano, Sara ^d,g   Previtali, Stefano ^d,g   Scarlato, Marina ^d,g   Natali Sora, MariaGrazia ^d,g   Mercuri, Eugenio ^e,g   Bresolin, Nereo ^a,g   Mongini, Tiziana ^f,g   Comi, Giancarlo ^d,g   Gatti, Roberto ^c,g   Ciceri, Fabio ^d,g   Cossu, Giulio ^d,g   Torrente, Yvan ^a,g  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DUCHENNE MUSCULAR DYSTROPHY; FUNCTIONAL ASSESSMENT; HUMAN; LONGITUDINAL STUDY; MALE; MUSCLE STRENGTH; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; WALKING;

ADOLESCENT; CHILD, PRESCHOOL; HUMANS; LONGITUDINAL STUDIES; MALE; MUSCLE STRENGTH; MUSCLE STRENGTH DYNAMOMETER; MUSCULAR DYSTROPHY, DUCHENNE; PHYSICAL EXAMINATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84866064194     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-91     Document Type: Article

References (29)

1. Kakulas BA. Observations on the pathogenesis of duchenne muscular dystrophy in the light of recent progress in molecular genetics. Aust Paediatr J 1988, 24(Suppl 1):4-8.
2. Drousiotou A, Ioannou P, Georgiou T, et al. Neonatal screening for duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in cyprus. Genet Test 1998, 2:55-60. 10.1089/gte.1998.2.55, 10464597.
3. Parsons EP, Bradley DM, Clarke AJ. Newborn screening for duchenne muscular dystrophy. Arch Dis Child 2003, 88:91-92. 10.1136/adc.88.1.91, 1719275, 12495985.
4. Siciliano G, Tessa A, Renna M, et al. Epidemiology of dystrophinopathies in North-West Tuscany: a molecular genetics-based revisitation. Clin Genet 1999, 56:51-58. 10.1034/j.1399-0004.1999.560107.x, 10466417.
5. Merlini L, Stagni SB, Marri E, Granata C. Epidemiology of neuromuscular disorders in the under-20 population in Bologna Province, Italy. Neuromuscul Disord 1992, 2:197-200. 10.1016/0960-8966(92)90006-R, 1483045.
6. Giacanelli M, Gneo S, Liguori M, Tarsitani G, Tessarolo D. Clinico-epidemiologic study of duchenne muscular dystrophy. Nuovi Ann Ig Microbiol 1988, 39:129-135.
7. McDonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test in duchenne/becker muscular dystrophy: longitudinal observations. Muscle Nerve 2010, 42(6):966-974. 10.1002/mus.21808, 21038378.
8. Law PK, Goodwin TG, Fang Q, et al. Feasibility, safety, and efficacy of myoblast transfer therapy on duchenne muscular dystrophy boys. Cell Transplant 1992, 1:235-244.
9. Tremblay JP, Malouin F, Roy R, et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with duchenne muscular dystrophy. Cell Transplant 1993, 2:99-112.
10. Verdijk LB, van Loon L, Meijer K, Savelberg HH. One-repetition maximum strength test represents a valid means to assess leg strength in vivo in humans. J Sports Sci 2009, 27:59-68. 10.1080/02640410802428089, 19031334.
11. Drouin JM, Valovich-mcLeod TC, Shultz SJ, Gansneder BM, Perrin DH. Reliability and validity of the biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements. Eur J Appl Physiol 2004, 91:22-29. 10.1007/s00421-003-0933-0, 14508689.
12. Moxley RT, Pandya S, Ciafaloni E, Fox DJ, Campbell K. Change in natural history of duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol 2010, 25:1116-1129. 10.1177/0883073810371004, 20581335.
13. Chakkalakal JV, Thompson J, Parks RJ, Jasmin BJ. Molecular, cellular, and pharmacological therapies for duchenne/becker muscular dystrophies. FASEB J 2005, 19:880-891. 10.1096/fj.04-1956rev, 15923398.
14. Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children: a prospective study in duchenne muscular dystrophy. Muscle Nerve 1982, 5:291-301. 10.1002/mus.880050405, 7099196.
15. Mathur S, Lott DJ, Senesac C, et al. Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with duchenne muscular dystrophy. Arch Phys Med Rehabil 2010, 91:1051-1058. 10.1016/j.apmr.2010.03.024, 20599043.
16. Mazzone E, Martinelli D, Berardinelli A, et al. North star ambulatory assessment, 6-minute walk test and timed items in ambulant boys with duchenne muscular dystrophy. Neuromuscul Disord 2010, 20:712-716. 10.1016/j.nmd.2010.06.014, 20634072.
17. Brussock CM, Haley SM, Munsat TL, Bernhardt DB. Measurement of isometric force in children with and without duchenne's muscular dystrophy. Phys Ther 1992, 72:105-114.
18. Buyse GM, Goemans N, Henricson E, et al. CINRG pilot trial of oxatomide in steroid-naive duchenne muscular dystrophy. Eur J Paediatr Neurol 2007, 11:337-340. 10.1016/j.ejpn.2007.02.009, 17459739.
19. Mayhew JE, Florence JM, Mayhew TP, et al. Reliable surrogate outcome measures in multicenter clinical trials of duchenne muscular dystrophy. Muscle Nerve 2007, 35:36-42. 10.1002/mus.20654, 16969838.
20. Fowler WM, Gardner GW. Quantitative strength measurements in muscular dystrophy. Arch Phys Med Rehabil 1967, 48:629-644.
21. Hogrel JY, Payan CA, Ollivier G, et al. Development of a french isometric strength normative database for adults using quantitative muscle testing. Arch Phys Med Rehabil 2007, 88:1289-1297. 10.1016/j.apmr.2007.07.011, 17908571.
22. Mazzone ES, Messina S, Vasco G, et al. Reliability of the north star ambulatory assessment in a multicentric setting. Neuromuscul Disord 2009, 19:458-461. 10.1016/j.nmd.2009.06.368, 19553120.
23. McDonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test as a new outcome measure in duchenne muscular dystrophy. Muscle Nerve 2010, 41:500-510. 10.1002/mus.21544, 19941337.
24. Munsat TL. Development of measurement techniques. Neurology 1996, 47:S83-S85. 10.1212/WNL.47.4_Suppl_2.83S, 8858056.
25. Escolar DM, Henricson EK, Pasquali L, Gorni K, Hoffman EP. Collaborative translational research leading to multicenter clinical trials in duchenne muscular dystrophy: the cooperative international neuromuscular research group (CINRG). Neuromuscul Disord 2002, 12(Suppl 1):S147-S154.
26. Wyse JP, Mercer TH, Gleeson NP. Time-of-day dependence of isokinetic leg strength and associated interday variability. Br J Sports Med 1994, 28:167-170. 10.1136/bjsm.28.3.167, 1332060, 8000814.
27. Droste SK, Collins A, Lightman SL, Linthorst AC, Reul JM. Distinct, time-dependent effects of voluntary exercise on circadian and ultradian rhythms and stress responses of free corticosterone in the rat hippocampus. Endocrinology 2009, 150:4170-4179. 10.1210/en.2009-0402, 2871297, 19477935.
28. Ives JC, Shelley GA. Psychophysics in functional strength and power training: review and implementation framework. J Strength Cond Res 2003, 17:177-186.
29. Househam E, McAuley J, Charles T, Lightfoot T, Swash M. Analysis of force profile during a maximum voluntary isometric contraction task. Muscle Nerve 2004, 29:401-408. 10.1002/mus.10564, 14981740.